Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axcellerate Pharma is a private U.S. contract research and contract development and manufacturing organization serving biopharma customers. The company provides drug product development, analytical methods development, organic synthesis, biologics development, chemical development, aseptic fill-finish, and early cGMP manufacturing services for both large and small molecules. Its capabilities span API and intermediates manufacturing, sterile injectables, lyophilization, microbial fermentation, mammalian cell culture, PEGylation, and oligonucleotide-related work. Based in Piscataway, New Jersey, Axcellerate appears to operate primarily as a fee-for-service CRO/CDMO rather than as a therapeutics developer with a disclosed proprietary clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axcellerate Pharma.